This MedLibrary.org supplementary page on Tamsulosin is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| This article does not cite any references or sources. (March 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
|
Tamsulosin
|
|
| Systematic (IUPAC) name | |
| (R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)- 2-methoxybenzenesulfonamide |
|
| Identifiers | |
| CAS number | |
| ATC code | G04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H28N2O5S |
| Mol. mass | 408.51 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | 100% (oral) |
| Metabolism | hepatic |
| Half life | 9–13 hours |
| Excretion | 76% renal |
| Therapeutic considerations | |
| Pregnancy cat. |
B2 (Aust) |
| Legal status | |
| Routes | oral |
Tamsulosin (rINN) (pronounced /tæmˈsuːloʊsɪn/, /tæmsuˈloʊsɪn/) is an α1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and is marketed by various companies under licence, including Boehringer-Ingelheim and CSL. Tamsulosin hydrochloride extended-release tablets are marketed under the trade name Flomaxtra and Urimax. It was formerly marketed as modified-release capsules under the trade name Flomax.
Contents |
Clinical use
Adverse effects
Two ADRs (Adverse Drug Reactions) have been reported:
- Immunologic: It contains a sulfa moiety, thus causing typical reactions to sulfa drugs.
- Ophthalmologic: Patients taking tamsulosin are prone to a complication known as floppy iris syndrome during cataract surgery. Adverse outcomes of the surgery are greatly reduced by the surgeon's prior knowledge of the patient's history with this drug, and thus having the option of alternative techniques. [1]
Tamsulosin has also affected the sexual function in men. Tamsulosin can cause males to experience retrograde ejaculation.
Clinical comparison
Although prostate specific, it does not have the prostate apoptotic effects of other alpha-blockers such as doxazosin and terazosin.
Use in Combination Therapy
The results of the CombAT (Combination of Avodart and Tamsulosin) trial have recently demonstrated that treatment with the combination of dutasteride and tamsulosin provides superior symptom benefits compared with either monotherapy (http://www.ncbi.nlm.nih.gov/pubmed/18082216?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum).
External links
- Tamsulosin (systemic) – information from USP DI Advice for the Patient
- Flomax (drugs.com) – U.S. product information
- Flomax (Official Site) – Official Site
|
|||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 29 May 2008, at 18:36.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Tamsulosin".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.
